ProteoCell Laboratories

ProteoCell Biotechnologies is a Canadian bioprocess specialty company based in Laval, Quebec, that focuses on the development and production of recombinant biopharmaceutical products. Founded in 2003, the company provides a range of services including cell line development, bioprocess scale-up, and protein purification to assist biotechnology and pharmaceutical firms in transitioning from discovery to clinical stages. ProteoCell's expertise spans the production of monoclonal antibodies, recombinant proteins, and biosimilars, with a notable emphasis on recombinant human insulin (Protelin). Operating as a contract research and development organization (CRDO/CDMO), the company offers turnkey solutions for biomanufacturing and international technology transfer. ProteoCell has established strategic partnerships, such as its historical joint venture with Viropro Inc., to commercialize biogeneric therapeutics for global markets.